Biotech Values

[bladerunner1717]

Thanks, Dew.

BTW, I don't know if you listened to the CC, but I thought it was really lame. If I had to hear one more time how MRK was the greatest company on the face of the planet, I thought I'd puke. The questioners (analysts) constantly asked questions that they had to know in advance that management wouldn't answer. And they didn't ask much more important questions about the nature of the talks with the FDA and the plans for the Phase III in the U.S. or questions about the Phase II in lung cancer or questions about the specific group of patients that would be looked at in the European trial or questions about the use and value of E20.

In short, I thought a lot of the CC was taken up with congratulatory and self-congratulatory tripe. (The CEO began to sound like Raj Shrotriya without the accent.) I mean I hate to say this about a company that is my third largest position, but I wasn't impressed at all by the presentation or the questions. Now I know you've listened to a million more of these than I have and you know a lot better how to interpret what is being said, so I'm asking whether this is typical of this kind of CC. And why do analysts who are certainly not stupid continually ask questions that they know will not be answered and avoid asking questions that might be of real interest and might actually get answered?


Bladerunner